Isolde H.
- Country
- Austria
- Department
- Kepleruniversitätsklinikum, Neuromed Campus, Konsiliardienst Innere Medizin und Neuroonkologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 26 partner sites.
Specializations
Central Nervous System Tumor Therapy
Focus on therapeutic strategies for central nervous system tumors within an internal medicine framework.
- Targeted agents for glioma
- Combination regimens with radiotherapy
- Management of treatment‑related toxicity
Clinical insight integrates systemic disease control with neuro‑oncologic considerations.
Immunotherapy in Neuro‑Oncology
Exploration of immune‑modulating approaches for malignant brain disease.
- Checkpoint inhibition in glioblastoma
- Adoptive cell therapies for CNS lesions
- Biomarker‑guided patient selection
Therapeutic focus aligns with emerging immune strategies in neuro‑oncology.
Molecular Diagnostics for Brain Malignancies
Implementation of advanced genomic profiling to guide treatment decisions.
- Next‑generation sequencing for tumor classification
- Detection of actionable mutations
- Integration of liquid biopsy data
Diagnostic precision supports personalized therapeutic pathways.
Palliative Care in Neuro‑Oncologic Patients
Optimizing symptom management and quality of life for individuals with advanced brain tumors.
- Neuropathic pain control
- Cognitive function preservation
- End‑of‑life decision support
Care strategies address complex needs of neuro‑oncology patients.
Translational Research in Neuro‑Oncology
Bridging laboratory discoveries with clinical application in brain cancer treatment.
- Preclinical validation of novel targets
- Pharmacokinetic studies in CNS environments
- Collaborative multicenter data sharing
Efforts aim to accelerate therapeutic innovation for neuro‑oncologic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.